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SUMMARY
Sperm chromatin/DNA damage can be measured by a variety of assays. However, it has been reported that these tests may lose
prognostic value in Assisted Reproductive Technology (ART) cycles when assessed in post-prepared samples, possibly due to the nor-
malizing effect promoted by sperm preparation procedures. We have recently implemented a modified version of the Diff-Quik
staining assay that allows for the evaluation of human sperm chromatin status in native samples, together with standard sperm mor-
phology assessment. However, the value of this parameter in terms of predicting in vitro fertilization (IVF) and Intracytoplasmic
sperm injection (ICSI) outcomes after sperm selection is unknown. In this study, data from 138 couples undergoing in vitro fertiliza-
tion (IVF) or Intracytoplasmic sperm injection (ICSI) treatments showed that sperm chromatin integrity was significantly improved
after density gradient centrifugation and swim up (p < 0.001), but no correlations were found with fertilization or embryo develop-
ment rates (p > 0.05). However, sperm samples presenting lower percentages of damaged chromatin were associated with better
quality (Grade I) embryos in both ART procedures (p < 0.05) and clinical pregnancy among IVF couples (p < 0.05). Furthermore,
regression analysis confirmed the clinical value of Diff-Quik staining in predicting IVF (but not ICSI) clinical pregnancy (OR: 0.927,
95% CI: 0.871–0.985, p = 0.015), and a threshold value of 34.25% for this parameter was established. The proportion of IVF couples
achieving a clinical pregnancy was reduced 1.9-fold when the percentage of abnormal dark staining was ≥34.25% (p = 0.05). In
conclusion, the Diff-Quik staining assay provides useful information regarding ART success, particularly in IVF cycles, where some
degree of ‘natural’ sperm selection may occur; but not in ICSI, where sperm selection is operator dependent. This quick and low-cost
assay is suggested as an alternative method to detect sperm chromatin status in minimal clinical settings, when no other well-estab-
lished and robust assays (e.g. Sperm chromatin structure assay, terminal deoxynucleotidyl transferase-mediated dUDP nick-end
labelling) are available.
INTRODUCTION
Male (in)fertility diagnosis usually relies on the microscopic
assessment of standard WHO-determined semen parameters –
sperm concentration, motility and morphology – in the native,
unprocessed, sample. However, emerging reports have shown
that sperm DNA integrity, required for the proper delivery of the
paternal genome to the offspring, may be a better predictor of
male fertilizing potential (Agarwal & Allamaneni, 2004; Bungum
et al., 2011). Indeed, substantially higher levels of sperm DNA
damage have been reported in both infertile men with normal
and abnormal standard semen parameters, when compared with
fertile donors (Saleh et al., 2002; Zini et al., 2002; Sergerie et al.,
2005). As a consequence, DNA damage has been often related to
a wide variety of poor reproductive outcomes, including
decreased fertilization rates (Sun et al., 1997; Velez de La Calle
et al., 2008; Simon et al., 2011), impaired embryo development
(Muriel et al., 2006a; Benchaib et al., 2007), lower embryo qual-
ity (Saleh et al., 2003; Velez de La Calle et al., 2008; Simon et al.,
2011), reduced chances of pregnancy (Saleh et al., 2003; Henkel
et al., 2004; Borini et al., 2006) and increased risk of fathering a
child with genetic anomalies (Marchetti & Wyrobek, 2005; Aitken
& Koppers, 2011). Regardless, the existing data are conflicting,
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especially when it concerns the relationship between DNA dam-
age and fertilization rates (Sun et al., 1997; Gandini et al., 2004;
Lin et al., 2008; Velez de La Calle et al., 2008; Simon et al., 2011).
Sperm chromatin structure assay (SCSA; Evenson et al., 1980),
terminal deoxynucleotidyl transferase-mediated dUDP nick-end
labelling assay (TUNEL; Gorczyca et al., 1993), Comet (single-
cell gel electrophoresis assay; Hughes et al., 1996) and sperm
chromatin dispersion test (commercially available as the Halo-
sperm kit; Fernandez et al., 2003) are well-described tests that
monitor sperm chromatin/DNA status, but there is still no con-
sensus on which test should be preferentially used (Zini & Sig-
man, 2009). As they involve extensive procedures and/or
expensive reagents and equipment, sperm DNA analysis has not
been routinely established in most standard Andrology laborato-
ries (Perreault et al., 2003).
Recently, we have described a simple, inexpensive and quick
method to analyse sperm chromatin status in both feline and
human spermatozoa using a simple modification in the Diff-
Quik stain, a stain already implemented worldwide to evaluate
sperm morphology under a standard bright-field microscope,
by detecting spermatozoa with different colour intensities
using a very short staining protocol (Mota & Ramalho-Santos,
2006; Sousa et al., 2009). In fact, there was a high correlation
between the proportion of spermatozoa with dark stained
nuclei and TUNEL-positive cells assayed in the same samples.
Moreover, a significant increase in spermatozoa with dark
nuclei was detected when male gametes were exposed to
DNAse I, hydrogen peroxide and heat, conditions known to
promote DNA fragmentation and chromatin decondensation
in vitro. Taken together, these data suggest that a modified
Diff-Quik stain can also be indicative of abnormal/damaged
sperm chromatin (either decondensed or with fragmented
DNA). A possible mechanism is that, as is the case with other
DNA dyes, changes in chromatin/DNA create more stain-bind-
ing sites, thus increasing the percentage of sperm nuclei with
a darker colour (Sousa et al., 2009). As observed with other
assays, the abnormal chromatin status in native spermatozoa
assessed by the Diff-Quik method was negatively correlated
with embryo development rate and higher levels were associ-
ated with lower quality embryos and negative clinical pregnan-
cies among Assisted Reproductive Technology (ART) couples
(Sousa et al., 2009).
Density gradient centrifugation (DGC) and swim-up tech-
niques, either alone or in combination, often allow the selection
of motile spermatozoa with normal morphology for ART treat-
ments (Bungum et al., 2008). These procedures have also been
shown to improve chromatin/DNA integrity levels as detected
by a wide range of assays (Spano et al., 1999; Tomlinson et al.,
2001; Gandini et al., 2004; Marchesi et al., 2010), although
unchanged levels were also reported by a small number of stud-
ies (Zini et al., 1999; Muriel et al., 2006b). As theoretically only
the best spermatozoa are recovered after DGC and/or swim-up
selection, it is argued that a certain degree of homogenization
occurs (Tomlinson et al., 2001). Consequently, although some
DNA integrity tests, such as SCSA or TUNEL, have been shown
to predict ART fertilization and pregnancy rates in raw heteroge-
neous samples, some authors have reported that their prognos-
tic value is lost in both in vitro fertilization (IVF) and
Intracytoplasmic sperm injection (ICSI) when using homoge-
neous populations (Larson et al., 2000; Gandini et al., 2004; Seli
et al., 2004; Bungum et al., 2008), possibly because of this ‘nor-
malizing’ effect promoted by the sperm preparation techniques.
Thus, this work aimed at using the Diff-Quik staining assay to
(i) evaluate sperm chromatin status after DGC followed by
swim-up sperm preparation procedures; and (ii) assess its rela-
tionship with ART fertility outcomes in the motile sperm
fraction.
MATERIAL AND METHODS
All chemicals were supplied by Sigma-Aldrich (St. Louis, MO,
USA) unless stated otherwise.
Patients
This study was carried out in the Human Reproduction Service
at University Hospitals of Coimbra, Portugal, between January
2012 and February 2013. A total of 138 cycles (57 IVF and 81
ICSI) from 138 couples experiencing infertility for at least 1 year,
with no viral infections, and whose female partners were
<40 years old and presented baseline Follicle-stimulating hor-
mone (FSH)<12 IU/L were included in this study. Couples with
normal standard semen parameters according to the World
Health Organization criteria (WHO, 2010) were referred to IVF,
whereas ICSI was only performed on couples with poor sperm
quality (e.g. low concentration and/or motility), or with a previ-
ous history of failed IVF fertilization or low fertilization rates.
Sperm samples were used in agreement with the appropriate
ethical and Internal Review Board of the Institution, who
approved all the experimental work. All individuals signed
informed consent forms and samples were obtained by mastur-
bation after 3–5 days of sexual abstinence. Sperm cells were
treated according to the WHO guidelines (WHO, 2010).
Sperm preparation for ART
After sample collection and liquefaction, spermatozoa were
isolated by sequential DGC (Isolate Sperm Separation Medium;
Irvine Scientific, Santa Ana, CA, USA) and swim-up techniques
(Amaral et al., 2007; Sousa et al., 2011). Briefly, sperm samples
were placed on top of the upper layer (50%) and centrifuged at
528 9 g for 10 min. Spermatozoa previously collected from the
90% lower layer were then washed with Sperm Preparation Med-
ium (Origio Medicult, Jyllinge, Denmark) and centrifuged at
528 9 g for another 10 min. Motile cells were subsequently
allowed to swim up for 30 min at 37 °C and 5% CO2 in the latter
medium. The motile sperm fraction was used in ART.
Sperm chromatin status assessment from both unprocessed
samples and motile sperm fractions
Sperm chromatin status from both native samples and the
respective motile sperm fractions after sperm selection (n = 138)
was evaluated by the Diff-Quik (Dade Behring Inc., Newark, NJ,
USA) staining as stated elsewhere (Ramalho-Santos et al., 2007;
Sousa et al., 2009). This commercially available kit is composed
of a fixative (methanol), a dye that stains basic proteins red
(eosin) and a thiazin which stains sperm DNA blue. Briefly,
10 lL of the sample was dragged with a cover slip and allowed to
air dry. Slides were then sequentially dipped in each kit solution
for no longer than 10–20 sec each and finally rinsed in water to
remove excess dye. This step is crucial to avoid a uniformly dark
staining on all spermatozoa, useful to assess morphology, but
which does not provide any chromatin status information. Slides
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were observed under a bright-field microscope (Nikon Instru-
ments Inc., Melville, NY, USA) and staining features were con-
stantly evaluated within each slide. Both light- and darkly
stained sperm heads were visible in each slide, the latter repre-
senting abnormal chromatin status, as not only is their propor-
tion strongly correlated with the proportion of TUNEL-positive
cells (Mota & Ramalho-Santos, 2006; Sousa et al., 2009) but also
significantly increased when exposed to positive control condi-
tions reported to cause DNA fragmentation and chromatin
decondensation (Sousa et al., 2009). In general, changes in
sperm chromatin (and thus nuclear DNA), whether because of
DNA strand breaks or changes in compaction, may alter thiazin–
DNA interactions, leading to more dye-binding sites and there-
fore may raise the percentage of darker sperm nuclei (Sousa
et al., 2009). As such, the proportion of spermatozoa with abnor-
mal dark nuclei representing abnormal/damaged chromatin was
established after scoring 200 cells in four different fields in each
slide. Counts were performed blindly by at least two observers,
and intra- and inter-observer variability was negligible. No clini-
cal data were available to the researchers performing this
analysis.
Ovarian stimulation
Individualized ovarian stimulation protocols were performed
after evaluation of each patient reproductive status (e.g. ovarian
reserve and hormone levels). Long and short protocols of pitui-
tary desensitization with GnRH agonists and antagonists,
respectively, were performed. Follicular growth was stimulated
by recombinant FSH [37.5–325 IU/day GONAL-f (Merck Serono,
London, UK) or Puregon (N.V. Organon, Oss, the Netherlands)]
or hMG (50–300 IU/day Menopur; Ferring Pharmaceuticals,
West Drayton, UK) and when at least one leading follicle reached
a 18 mm diameter (monitored by ultrasound), ovulation was
induced with hCG (5000 IU Pregnyl; N.V. Organon). Ultrasound-
guided vaginal oocyte aspiration was performed 35–36 h post-
hCG administration.
IVF and ICSI protocols
Following sperm preparation and oocyte retrieval, IVF and
ICSI procedures were performed as previously described (Santos
et al., 2006). For ICSI cycles, cumulus cells were removed from
the cumulus–oocyte complexes (COCs) by incubation with
50 lL of hyaluronidase (SynVitro Hyadase; Origio Medicult) and
intermittent pipetting for a maximum of 30 sec. Sperm suspen-
sions were placed in SpermSlow medium (Origio Medicult) and
only free and motile spermatozoa were immobilized and
injected into the oocytes. For IVF, each COC insemination was
carried out with 100 000 selected spermatozoa. Injected and
inseminated oocytes were cultured at 37 °C and 6% CO2 in IVF
medium (Origio Medicult). Fertilization was assessed after
17–20 h.
Fertility outcome parameters
As previously described, fertilization and embryo development
rates were scored as the number of 2PN oocytes/number of
inseminated or injected oocytes and the number of embryos/
number of inseminated or injected oocytes respectively (Sousa
et al., 2009). Embryos were graded from I to IV in accordance
with the number, form and symmetry of blastomeres and the
presence of blastomere fragmentation 48 h post-fertilization
(Elder & Dale, 2000). Grade I embryos, that is embryos with regu-
lar blastomere shape and symmetry, light cytoplasmic appear-
ance and blastomere fragmentation of up to 10%, from couples
only displaying this high embryo quality were included in the
‘G1’ group, whereas couples having at least one embryo classi-
fied differently were included in the ‘other grade’ group (Sousa
et al., 2009). Embryo transfer rate was determined as the number
of transfers performed/number of cycles which obtained
embryos. Finally, clinical pregnancies were determined by ultra-
sound detection of the gestational sac(s) 4 weeks after embryo
transfer. Clinical pregnancy rate was scored as the number of
couples with positive clinical pregnancy detected by ultrasound/
number of transfers.
Statistical analysis
Statistical analysis was carried out using the SPSS version 20.0
software for Windows (SPSS Inc., Chicago, IL, USA). Values are
expressed as mean  SEM. All variables were checked for nor-
mal distribution by the Kolmogorov–Smirnov test (or the Shap-
iro–Wilk test for groups with n < 25) and the independent t-test
for normal variables were performed to compare dark sperm
staining before and after sperm selection, between the two
embryo quality groups and between pregnancy outcome groups
in both IVF and ICSI cycles. As fertilization and embryo develop-
ment rates presented a non-normal distribution, Spearman’s
non-parametric correlation coefficient test was performed to
determine if there were any correlations with dark sperm stain-
ing. The sample sizes used in this study provided power values
equal or greater than 80% to detect a 10–15% difference in the
proportion of dark sperm staining between groups in each con-
dition assessed, using the independent t-test, p < 0.05 and 95%
CIs. Demographic data comparisons between ART treatments
and pregnant vs. non-pregnant couples were performed by the
independent t-test or the related Mann–Whitney test for non-
normal variables and the chi-squared test for categorical data.
Logistic regression analysis was carried out to assess the predic-
tive value of several factors in ART pregnancy outcomes. Recei-
ver operating characteristic (ROC) curve analysis allowed the
determination of a significant threshold for clinical pregnancy
following IVF and the chi-squared test was performed to find a
possible threshold effect. Statistically significant differences
were considered when p ≤ 0.05.
RESULTS
Characteristics of the study population
Demographic data from 57 IVF and 81 ICSI cycles are dis-
played in Table 1. Although female factor was the main cause of
infertility in both IVF and ICSI couples (64.91 and 51.90%
respectively), the percentage of couples experiencing infertility
exclusively because of a male factor was significantly higher
among couples referred to ICSI cycles (22.78 and 1.75%
p = 0.001). As one of the criteria used to perform ICSI is poor
semen quality (e.g. low concentration and/or motility),
the decrease observed in the sperm concentration of these
patients was not surprising (74.21  6.88 9 106/mL and
93.40  6.5 9 106/mL, p = 0.018). However, total motility (pro-
gressive motility + in situ) did not differ between treatments
(p > 0.05). Among IVF couples, the number of inseminated/
injected (11.03  0.88 and 4.07  0.32, p < 0.001) and fertilized
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oocytes (6.11  0.62 and 2.49  0.20, p < 0.001) as well as the
number of embryos retrieved (4.85  0.50 and 2.09  0.13,
p < 0.001) were significantly higher than the ones obtained by
couples undergoing ICSI treatments. No differences were
observed regarding male and female age, type and duration of
infertility; and fertilization, embryo development, embryo trans-
fer or clinical pregnancy rates (p > 0.05, Table 1).
Levels of sperm chromatin damage after DGC and swim-up
selection
To potentially maximize ART outcomes, and thus achieve
pregnancy, spermatozoa are traditionally processed by DGC
and/or swim-up procedures. In our unit, these procedures are
routinely carried out sequentially, not as alternatives. Sperm
chromatin integrity was significantly improved after this selec-
tion, as observed by the decreased proportion of abnormal dark
staining in the motile sperm fraction when compared with their
unprocessed counterparts (41.13  2.15 and 51.40  1.92,
n = 138; p < 0.001, Fig. 1). It seems therefore that the Diff-Quik
staining is able to efficiently detect an enrichment of spermato-
zoa with chromatin integrity in post-prepared samples, as others
have reported using different assays (Spano et al., 1999; Tomlin-
son et al., 2001; Gandini et al., 2004; Marchesi et al., 2010).
Chromatin damage, fertilization and embryo development
rates
No correlation was detected between the percentage of sper-
matozoa with dark nuclei and IVF (q = 0.105, n = 57, p > 0.05)
or ICSI fertilization rates (q = 0.123, n = 81, p > 0.05). More-
over, the same lack of association was found between abnormal
dark staining and embryo development rates in both IVF and
ICSI cycles (q = 0.029, n = 51 and q = 0.067, n = 74, respec-
tively, p > 0.05).
Chromatin damage, embryo quality and clinical pregnancy
To further determine if dark sperm nuclei had any relevance
in terms of embryo quality, embryos were graded from I to IV
according to several embryo features (Elder & Dale, 2000) and
couples with only good quality embryos, commonly classified as
Grade I, were included in the ‘G1’ group, whereas couples who
had at least one embryo with a different grade were included in
the ‘other grade’ group. For IVF cycles, samples that generated
the ‘G1’ group had a significant lower proportion of spermatozoa
with dark staining (32.41  4.03%, n = 22, and 47.04  5.77%,
n = 22, respectively, p = 0.044). Similarly, ICSI couples included
in the ‘G1’ group (n = 38) presented a significantly lower per-
centage of dark sperm staining than the ones (n = 30) in the
‘other grade’ group (35.26  3.97 and 47.8  4.69%, respec-
tively, p = 0.044).
Several factors may influence the achievement of pregnancy
in both IVF and ICSI treatments (Table 2). Pregnant IVF couples
presented a higher number of inseminated (11.22  0.95 and
9.00  1.39, p = 0.023) and fertilized oocytes (6.78  0.70 and
4.89  0.60, p = 0.031) and a decreased proportion of spermato-
zoa with dark nuclei (36.89  4.52 and 51.75  5.63%,
p = 0.047) than their non-pregnant counterparts (Table 2). On
the other hand, only the number of embryos obtained
(2.60  0.19 and 2.09  0.14, p = 0.05) and transferred
(2.40  0.16 and 1.89  0.12, p = 0.023) were significantly
increased among couples who became pregnant following an
ICSI cycle (Table 2). However, no difference was found between
the percentages of dark stained sperm when pregnant and non-
pregnant ICSI groups were compared (35.45  4.40% and
44.93  4.15%, p > 0.05, Table 2). From all the variables listed in
Table 2, only female age (OR: 0.632; 95% CI: 0.431–0.926,
p = 0.018, Table 3), total sperm motility (OR: 1.092; 95% CI:
1.016–1.174, p = 0.017, Table 3) and dark sperm staining (OR:
0.927, 95% CI: 0.871–0.985, p = 0.015, Table 3) were found to be
predictors of clinical pregnancy among IVF cycles. Although
female age seems to be the factor that most contributes to
Table 1 Background information on both IVF and ICSI cycles
IVF ICSI p-value
Cycles/couples included (n) 57 81
Female age (years  SEM) 33.00  0.49 33.14  0.36 >0.05
Male age (years  SEM) 35.16  0.73 35.37  0.57 >0.05
Diagnosis of infertility (%)
Unexplained 21.05 12.66 >0.05
Male factor 1.75 22.78 0.001
Female factor 64.91 51.90 >0.05
Male and female factors 12.28 12.66 >0.05
Type of infertility (%)
Primary 72.73 72.15 >0.05
Secondary 27.27 27.85 >0.05
Duration of infertility
(years  SEM)
5.16  0.45 6.09  0.35 >0.05
No. of inseminated/injected
oocytes (mean  SEM)
11.03  0.88 4.07  0.32 <0.001
No. of 2PN oocytes
(mean  SEM)
6.11  0.62 2.49  0.20 <0.001
Fertilization rate (%) 57.22  3.77 64.33  3.53 >0.05
No. of embryos
(mean  SEM)
4.85  0.50 2.09  0.13 <0.001
Embryo development rate (%) 50.00  3.44 56.70  3.37 >0.05
No of transferred embryos
(mean  SEM)
1.95  0.07 2.05  0.01 >0.05
Embryo transfer rate (%) 86 94.2 >0.05
Clinical pregnancy rate (%) 41.86 27.69 >0.05
Mean sperm concentration
(106/mL  SEM)
93.40  6.50 74.21  6.88 0.018
Sperm motility
(mean %  SEM)
60.89  2.52 56.68  2.46 >0.05
2PN: 2 pronuclei. Fertilization rate = number of 2PN oocytes/number of insemi-
nated or injected oocytes; Embryo development rate = number of embryos/
number of inseminated or injected oocytes; Embryo transfer rate = number of
transfers performed/number of cycles that obtained embryos; Clinical pregnancy
rate = number of pregnant couples/number of transfers.
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Figure 1 Mean proportion of abnormal dark staining spermatozoa in both
the native and motile sperm fractions (following sequential application of
density gradient and swim up) from the same samples (n = 138).
***p < 0.001.
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pregnancy success in IVF treatments in this particular study,
sperm Diff-Quik staining foresees a decrease in pregnancy
chances of 7.3% per each 1% increase in abnormal dark staining
observed. Contrary to this, the number of embryos obtained
(OR: 4.054; 95% CI: 1.308–12.561, p = 0.015, Table 3), but not
sperm staining (OR: 1.01, 95% CI: 0.957–1.106, p > 0.05), was
predictive of clinical pregnancy for ICSI cycles.
Considering the prognostic value of this modified Diff-Quik
assay in IVF pregnancy success a ROC analysis was performed,
in an attempt to identify a threshold value for dark sperm stain-
ing beyond which clinical pregnancy would be compromised.
With an area under the curve of 0.700 cm2 (p = 0.046), a thresh-
old value was set at 34.25% with a sensitivity of 77.8% and a
specificity of 52.9%. The proportion of pregnant couples having
an abnormal dark staining ≥34.25% was found to be reduced 1.9-
fold when compared with the fraction of pregnant couples with
sperm dark nuclei below this cut-off (p = 0.05).
DISCUSSION
Routine semen analysis does not include the evaluation of
sperm DNA damage, despite the multitude of available assays.
This lack of assessment has been extensively criticized, as it has
become more evident that men with normal standard semen
parameters may possess abnormal levels of DNA damage (Agar-
wal & Allamaneni, 2004), thus potentially contributing to the
limited success of ART.
Recently, we modified the Diff-Quik staining method to allow
the assessment of sperm morphology and abnormal chromatin
status in the same slides, by detecting spermatozoa with dark
stained nuclei (Mota & Ramalho-Santos, 2006; Sousa et al.,
2009). Despite its clinical value, when used in unprocessed sam-
ples, its relationship with ART fertility outcomes after sperm
selection was further probed in this study. As many tests may
lose their predictive value when assessed in post-prepared sam-
ples (Larson et al., 2000; Gandini et al., 2004; Seli et al., 2004;
Muriel et al., 2006b; Bungum et al., 2008), it has been suggested
that the evaluation of sperm DNA integrity must be carried out
in the whole ejaculate when it concerns in vivo conception, and
after sperm selection when ART treatments are used (Tomlinson
et al., 2001).
Sperm preparation techniques such as DGC and swim up
favour the selection of live, highly motile and morphologically
normal spermatozoa that will be used in ART cycles (Bungum
et al., 2008). However, some conflicting results exist on whether
these techniques, alone or in combination, select spermatozoa
with lower levels of DNA damage. Nevertheless, as also previ-
ously reported by several authors (Spano et al., 1999; Tomlinson
et al., 2001; Gandini et al., 2004; Marchesi et al., 2010), a signifi-
cant improvement in sperm chromatin integrity following sperm
preparation procedures, was found in this study, thus suggesting
the use of better quality spermatozoa in ART procedures. Fur-
thermore, these results support the clinical usefulness of this
modified Diff-Quik staining assay.
Although many reports have indicated an obvious influence of
sperm DNA damage on fertilization rates (Sun et al., 1997; Lopes
et al., 1998; Benchaib et al., 2003; Velez de La Calle et al., 2008;
Simon et al., 2011), we did not observe any relationship between
abnormal chromatin status, as monitored by this assay, and fer-
tilization rates in both IVF and ICSI treatments. These findings
are, however, in agreement with several other studies involving
both IVF (Tomlinson et al., 2001; Tomsu et al., 2002; Henkel
et al., 2003, 2004; Lin et al., 2008) and ICSI cycles (Høst et al.,
2000; Henkel et al., 2003; Lin et al., 2008). Given that the activa-
tion of the paternal genome is thought to occur only at 4–8-cell
stage embryo (Borini et al., 2006), paternal chromatin status
might not greatly affect fertilization (Ahmadi & Ng, 1999). How-
ever, abnormal levels of DNA damage may influence later stages
of development (Virro et al., 2004; Borini et al., 2006; Simon
et al., 2010). In this study, we failed to observe any relationship
between the percentages of dark sperm nuclear staining and
embryo development rates in post-prepared samples in both IVF
and ICSI cycles, but embryo quality and, importantly, pregnancy
success were adversely affected by abnormal chromatin status
monitored by this assay. Abnormal dark staining was found to
Table 2 Comparison of several variables among pregnant and non-pregnant couples undergoing IVF or ICSI treatments
IVF ICSI
Pregnant Non-pregnant p-value Pregnant Non-pregnant p-value
No. of couples/cycles included 18 25 18 47
Female age (years  SEM) 31.67  0.79 33.72  0.93 >0.05 34.27  0.62 32.59  0.51 >0.05
Male age (years  SEM) 33.33  0.67 35.65  1.50 >0.05 35.91  1.22 35.17  0.88 >0.05
No. of inseminated/injected oocytes (mean  SEM) 11.22  0.95 9.00  1.39 0.023 3.93  0.37 4.61  0.50 >0.05
No. of 2PN oocytes (mean  SEM) 6.78  0.70 4.89  0.60 0.031 3.13  0.34 2.77  0.28 >0.05
Fertilization rate (mean %  SEM) 63.87  5.68 60.57  5.29 >0.05 81.00  5.07 68.80  4.06 >0.05
No. of embryos (mean  SEM) 5.17  0.54 4.44  0.59 >0.05 2.60  0.19 2.09  0.14 0.05
Embryo development rate (mean %  SEM) 50.70  6.07 53.36  4.75 >0.05 71.33  6.05 58.21  4.13 >0.05
No. of transferred embryos (mean  SEM) 2.11  0.08 1.89  0.11 >0.05 2.40  0.16 1.89  0.12 0.023
Mean sperm concentration (106/mL  SEM) 112.22  9.55 85.39  12.45 >0.05 89.14  18.26 72.25  8.76 >0.05
Motility (mean %  SEM) 68.83  3.30 58.67  4.51 >0.05 63.47  3.83 55.55  3.74 >0.05
Abnormal dark staining (mean %  SEM) 36.89  4.52 51.75  5.63 0.047 35.45  4.40 44.93  4.15 >0.05
2PN: 2 pronuclei. Fertilization rate = number of 2PN oocytes/number of inseminated or injected oocytes; Embryo development rate = number of embryos/number of
inseminated or injected oocytes.
Table 3 Odds ratio and 95% CI from several predictors of clinical preg-
nancy success in both IVF and ICSI cycles
OR (95% CI) p-value
IVF Female age 0.632 (0.431–0.926) 0.018
Motility 1.092 (1.016–1.174) 0.017
Abnormal dark staining 0.927 (0.871–0.985) 0.015
ICSI No. of embryos 4.054 (1.308–12.561) 0.015
OR: odds ratio; CI: confidence interval.
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have a small, but significant prognostic value in terms of preg-
nancy achievement when using IVF. Obviously one may not
exclude that several other factors besides sperm chromatin/DNA
damage (e.g. female age) may also influence these reproductive
parameters.
Reports focusing on the relationship between DNA damage
assessed after sperm preparation techniques, and embryo and
pregnancy outcomes in ART are conflicting probably because
the type and degree of DNA injury differs among studies, as do
the DNA integrity assays employed. Recently, Simon et al. (2010)
have also found a decrease in embryo quality and pregnancy
rates with increased sperm DNA fragmentation assessed by the
Comet assay after DGC among IVF couples, but not between
pregnant and non-pregnant groups after ICSI cycles, as we also
show. However, contrary to what we describe, they failed to
observe any relationship with embryo quality after ICSI treat-
ments. In addition, an inverse correlation between embryo qual-
ity and Comet sperm DNA damage among IVF couples was
detected in processed samples by Tomsu et al.; however, no cor-
relation with pregnancy outcomes was shown (Tomsu et al.,
2002). In other studies, positive clinical pregnancies and lower
pregnancy loss rates were observed among ICSI couples that
presented a lower proportion of sperm with fragmented DNA
detected by TUNEL after DGC (Benchaib et al., 2003; Borini
et al., 2006). Conversely, others failed to observe any relationship
between DNA damage, evaluated in post-prepared spermatozoa
by SCSA, TUNEL or in situ nick translation, and embryo quality
or clinical pregnancies in IVF and/or ICSI cycles (Sun et al.,
1997; Larson et al., 2000; Tomlinson et al., 2001; Benchaib et al.,
2003; Gandini et al., 2004; Seli et al., 2004; Borini et al., 2006;
Bungum et al., 2008).
Although the percentage of spermatozoa with DNA damage
may considerably decrease after sperm preparation techniques,
as we demonstrate here, there is still a reasonable likelihood of
the technician choosing a spermatozoon with damaged chroma-
tin (i.e. partially decondensed chromatin and/or DNA damage)
when performing ICSI, which may explain our findings. This is
particularly worrisome given that DNA damage may not be fully
repaired by the oocyte machinery, but still allow for embryo
development, increasing the risk of conceiving a child with
genetic anomalies (Marchetti & Wyrobek, 2005; Aitken & Kop-
pers, 2011). On the other hand, our data suggest that there may
be some degree of ‘natural’ selection in IVF cycles, thus favour-
ing spermatozoa with no or less fragmented DNA to successfully
achieve pregnancy.
In this report, clinical pregnancy success was severely reduced
in IVF couples having at least 34.25% of (abnormal) dark
spermatozoa. Interestingly several other studies showed similar
cut-offs for IVF: lower pregnancy rates were reported when the
percentage of TUNEL-positive spermatozoa was ≥35 (Frydman
et al., 2008) or >36.5 (Henkel et al., 2003, 2004); and a similar
value of ≥30% was shown for the SCSA DNA fragmentation index
(Virro et al., 2004).
Taken together, the modified Diff-Quik staining provides use-
ful information about ART success in post-prepared samples,
particularly in IVF treatments where an operator does not
choose the spermatozoa that will fertilize the oocytes. However,
despite its low cost and simple methodology, this staining
involves the assessment of 200 cells per slide, displays a certain
degree of subjectivity, and exposure to the thiazin dye for longer
periods that those described here will produce a uniformly dark
staining that will compromise chromatin damage assessment.
Proper training, nevertheless, allows the achievement of consis-
tent and reproducible results, with minimal variability. Although
SCSA is a very robust assay that analyses 5000–10 000 sperm
cells, using objective, machine-defined criteria and with high
levels of repeatability (Evenson et al., 1999, 2002), it is not used
in most Andrology laboratories, nor are any other chromatin/
DNA integrity tests usually employed, at least as a routine proce-
dure. The need of extensive protocols and/or expensive reagents
and equipment (e.g. a flow cytometer and fluorescence micro-
scope) are limiting factors when the goal is to routinely imple-
ment DNA damage analysis worldwide. Based on our present
and previous results (Sousa et al., 2009), we therefore suggest
that the modified Diff-Quik staining method may provide an
alternative to detect sperm chromatin damage, in the absence of
more robust tests.
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